Literature DB >> 24218100

Cerebral vasculopathy in a Chinese family with neurofibromatosis type I mutation.

Jian-Tao Liang1, Li-Rong Huo, Yu-Hai Bao, Zhen-Yu Wang, Feng Ling.   

Abstract

Neurofibromatosis type I (NF1) is a hereditary, autosomal dominant, neurocutaneous syndrome that is attributed to NF1 gene mutation. NF1 has been associated with scoliosis, macrocephaly, pseudoarthrosis, short stature, mental retardation, and malignancies. NF1-associated vasculopathy is an uncommon and easily-overlooked presentation. Examination of a Chinese family affected by NF1 combined with cerebral vessel stenosis and/or abnormality suggested a possible relationship between NF1 and vessel stenosis. To determine which NF1 gene mutation is associated with vascular lesions, particularly cerebral vessel stenosis, we examined one rare family with combined cerebral vessel lesions or maldevelopment. Vascular lesions were detected using transcranial Doppler sonography and digital subtraction angiography in family members. Next, denaturing high-performance liquid chromatography and sequencing were used to screen for NF1 gene mutations. The results revealed a nonsense mutation, c.541C>T, in the NF1 gene. This mutation truncated the NF1 protein by 2659 amino-acid residues at the C-terminus and co-segregated with all of the patients, but was not present in unaffected individuals in the family. Exceptionally, three novel mutations were identified in unaffected family members, but these did not affect the product of the NF1 gene. Thus the nonsense mutation, c.541C>T, located in the NF1 gene could constitute one genetic factor for cerebral vessel lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218100      PMCID: PMC5562553          DOI: 10.1007/s12264-013-1388-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  25 in total

1.  Molecular diagnosis of neurofibromatosis type 1: 2 years experience.

Authors:  Siân Griffiths; Peter Thompson; Ian Frayling; Meena Upadhyaya
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

2.  Carotid sonography and transesophageal echocardiography in patients with ischemic stroke or transient ischemic attack in the territory of the carotid artery.

Authors:  Marjatta Strandberg; Reijo J Marttila; Arto Haapanen; Hans Helenius; Jaakko Hartiala
Journal:  J Clin Ultrasound       Date:  2006-10       Impact factor: 0.910

3.  Novel mutation of neurofibromatosis type 1 in a patient with cerebral vasculopathy and fatal ischemic stroke.

Authors:  Sung-Chun Tang; Ming-Jen Lee; Jiann-Shing Jeng; Ping-Keung Yip
Journal:  J Neurol Sci       Date:  2006-01-18       Impact factor: 3.181

4.  Identification of neurofibromatosis 1 (NF1) homologous loci by direct sequencing, fluorescence in situ hybridization, and PCR amplification of somatic cell hybrids.

Authors:  S M Purandare; H Huntsman Breidenbach; Y Li; X L Zhu; S Sawada; S M Neil; A Brothman; R White; R Cawthon; D Viskochil
Journal:  Genomics       Date:  1995-12-10       Impact factor: 5.736

5.  Transcranial Doppler correlation with angiography in detection of intracranial stenosis.

Authors:  M B Rorick; F T Nichols; R J Adams
Journal:  Stroke       Date:  1994-10       Impact factor: 7.914

6.  Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene.

Authors:  S S Han; D N Cooper; M N Upadhyaya
Journal:  Hum Genet       Date:  2001-10-11       Impact factor: 4.132

7.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

8.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

9.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

Authors:  J M Friedman; P H Birch
Journal:  Am J Med Genet       Date:  1997-05-16

10.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.